Products & ReviewLife Sciences

xCELLigence RTCA EPACER

Agilent TechnologiesAvailable: Worldwide

The xCELLigence RTCA ePacer provides an easy and effective way to produce functionally mature hiPSC cardiomyocytes. The ePacer improves the maturation status of the cardiomyocytes in 2-3 weeks using precise and electrical pacing conditions over different time durations. The simple pacing protocol, using precise and consistent electrical pacing conditions, improves the functionality of hiPSC cardiomyocytes and their response to…

Agilent Technologies

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our  Product Directory.

Ease of Use
After Sales Service
Value for Money
Write your own review

The xCELLigence RTCA ePacer provides an easy and effective way to produce functionally mature hiPSC cardiomyocytes. The ePacer improves the maturation status of the cardiomyocytes in 2-3 weeks using precise and electrical pacing conditions over different time durations. The simple pacing protocol, using precise and consistent electrical pacing conditions, improves the functionality of hiPSC cardiomyocytes and their response to inotropic compounds.

For Research Use Only. Not for use in diagnostic procedures.

Product Overview

Links